U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C21H30O4
Molecular Weight 346.4605
Optical Activity UNSPECIFIED
Defined Stereocenters 6 / 6
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Cortodoxone

SMILES

C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO

InChI

InChIKey=WHBHBVVOGNECLV-OBQKJFGGSA-N
InChI=1S/C21H30O4/c1-19-8-5-14(23)11-13(19)3-4-15-16(19)6-9-20(2)17(15)7-10-21(20,25)18(24)12-22/h11,15-17,22,25H,3-10,12H2,1-2H3/t15-,16+,17+,19+,20+,21+/m1/s1

HIDE SMILES / InChI

Molecular Formula C21H30O4
Molecular Weight 346.4605
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 6 / 6
E/Z Centers 0
Optical Activity UNSPECIFIED

11-Deoxycortisol (also known as cortodoxone) is the predominant deoxycorticosteroid and is the immediate precursor of cortisol, which is formed by the enzymatic action of 11beta-hydrozylase (P450). Deficiency of this enzyme causes congenital adrenal hyperplasia, which is characterized by hypertension. 11-deoxycortisol is measured as part of the Metyrapone Test. Metyrapone blocks the formation of cortisol, resulting in increased secretion of Adrenocorticotropic hormone (ACTH) and 11-deoxycortisol in normal individuals.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: P15538
Gene ID: 1584.0
Gene Symbol: CYP11B1
Target Organism: Homo sapiens (Human)
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Diagnostic
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Tissue culture of sockeye salmon intestine: functional response of Na+-K+-ATPase to cortisol.
2005-06
Insulin-like growth factor-I induces oocyte maturational competence but not meiotic resumption in white bass (Morone chrysops) follicles in vitro: evidence for rapid evolution of insulin-like growth factor action.
2005-05
11beta-Hydroxysteroid dehydrogenase type 2 activity is associated with left ventricular mass in essential hypertension.
2005-03
Identification of 17,20beta,21-trihydroxy-4-pregnen-3-one as an oocyte maturation-inducing steroid in black porgy, Acanthopagrus schlegeli.
2005-02
Genetic variation at the locus encompassing 11-beta hydroxylase and aldosterone synthase accounts for heritability in cortisol precursor (11-deoxycortisol) urinary metabolite excretion.
2005-02
11-deoxycorticosterone is a potent agonist of the rainbow trout (Oncorhynchus mykiss) mineralocorticoid receptor.
2005-01
Functional characterization of two novel point mutations in the CYP21 gene causing simple virilizing forms of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
2005-01
3alpha,5beta-Reduced cortisol exhibits antagonist properties on cerebral cortical GABA(A) receptors.
2004-12-15
Metyrapone tests in patients with panic disorder.
2004-12-01
Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial.
2004-12
Congenital adrenal hyperplasia with 11 beta-hydroxylase deficiency.
2004-11
A detailed investigation of hirsutism in a Turkish population: idiopathic hyperandrogenemia as a perplexing issue.
2004-10
Evidence that 4-pregnen-17,20beta,21-triol-3-one functions as a maturation-inducing hormone and pheromonal precursor in the percid fish, Gymnocephalus cernuus.
2004-10
Periconceptional undernutrition in sheep accelerates maturation of the fetal hypothalamic-pituitary-adrenal axis in late gestation.
2004-09
Aldosterone synthase gene variation and adrenocortical response to sodium status, angiotensin II and ACTH in normal male subjects.
2004-08
Differential actions of metyrapone on the fetal pituitary-adrenal axis in the sheep fetus in late gestation.
2004-08
Overnight metyrapone and combined dexamethasone/metyrapone tests in post-traumatic stress disorder: preliminary findings.
2004-08
Congenital adrenal hyperplasia secondary to 11beta-hydroxylase deficiency in a domestic cat.
2004-07-15
Visualizing the vitreous body in the anterior chamber using 11-deoxycortisol after posterior capsule rupture in an animal model.
2004-07
Lack of defects in androgen production in children with hypospadias.
2004-06
Steroid metabolism in vitro during final oocyte maturation in white croaker Micropogonias furnieri (Pisces: Sciaenidae).
2004-05
Steroid profiles using liquid chromatography-tandem mass spectrometry with atmospheric pressure photoionization source.
2004-04
The impact of polymorphisms in the gene encoding aldosterone synthase (CYP11B2) on steroid synthesis and blood pressure regulation.
2004-03-31
Gonad development and plasma steroid profiles by HRGC/HRMS during one reproductive cycle in reference and leachate-exposed female perch (Perca fluviatilis).
2004-03-01
Investigation of the hypothalamo-pituitary-adrenal axis (HPA) by 1 microg ACTH test and metyrapone test in patients with primary fibromyalgia syndrome.
2004-01
Endogenous urinary steroids in premenopausal women with uterine leiomyomas.
2004-01
Coexistence of different phenotypes in a family with glucocorticoid-remediable aldosteronism.
2004-01
Biological profile of cortexolone 17alpha-propionate (CB-03-01), a new topical and peripherally selective androgen antagonist.
2004
Surface-activated chemical ionization ion trap mass spectrometry in the analysis of 21-deoxycortisol in blood.
2004
Analysis of 21-deoxycortisol, a marker of congenital adrenal hyperplasia, in blood by atmospheric pressure chemical ionization and electrospray ionization using multiple reaction monitoring.
2004
The prevalence of late onset congenital adrenal hyperplasia in hirsute women from Central Anatolia.
2003-12
Reference values for urinary steroids in Japanese newborn infants: gas chromatography/mass spectrometry in selected ion monitoring.
2003-12
Flexibility of the endogenous progesterone lactonisation pathway in Aspergillus tamarii KITA: transformation of a series of cortical steroid analogues.
2003-12
The effect of intrafetal infusion of metyrapone on arterial blood pressure and on the arterial blood pressure response to angiotensin II in the sheep fetus during late gestation.
2003-10-15
Dexamethasone does not exert direct intracellular feedback on steroidogenesis in human adrenal NCI-H295A cells.
2003-10
Interrenal steroid 21-hydroxylase in eels: primary structure, progesterone-specific activity and enhanced expression by ACTH.
2003-10
Delta sleep response to metyrapone in post-traumatic stress disorder.
2003-09
The mineralocorticoid receptor agonist, fludrocortisone, inhibits pituitary-adrenal activity in humans after pre-treatment with metyrapone.
2003-08-22
Molecular cloning and expression of guinea pig cytochrome P450c21 cDNA (steroid 21-hydroxylase) isolated from the adrenals.
2003-08
Association of polymorphisms in the interleukin 6 receptor complex with obesity and hyperandrogenism.
2003-08
Evidence for two distinct functional glucocorticoid receptors in teleost fish.
2003-08
Ghrelin, an endogenous ligand for the growth hormone-secretagogue receptor, is expressed in the human adrenal cortex.
2003-08
Reversed-phase high-performance liquid chromatography separation of adrenal steroids prior to radioimmunoassay: application in congenital adrenal hyperplasia.
2003-07-05
Brief undernutrition in late-gestation sheep programs the hypothalamic-pituitary-adrenal axis in adult offspring.
2003-07
Concurrent corticosteroid and phenanthrene transformation by filamentous fungus Cunninghamella elegans.
2003-05
Membrane-initiated steroid signaling (MISS): genomic steroid action starts at the plasma membrane.
2003-05
[The 1(2)-dehydrogenation of steroid substrates by Nocardioides simplex VKM Ac-2033D].
2003-04-18
Air oxidation of 17-hydroxycorticosteroids catalyzed by cupric acetate: formation of hemiacetal dimers.
2003-04
Hypothalamic-pituitary-adrenocortical axis function in patients with polymyalgia rheumatica and giant cell arteritis.
2003-02
Adrenal insufficiency and abnormal genitalia in a 46XX female with Smith-Lemli-Opitz syndrome.
2003
Patents

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Mon Mar 31 17:35:01 GMT 2025
Edited
by admin
on Mon Mar 31 17:35:01 GMT 2025
Record UNII
WDT5SLP0HQ
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Cortodoxone
INN   USAN  
INN   USAN  
Official Name English
11-DEOXYCORTISOL
Preferred Name English
SK&F 3050
Code English
HYDROCORTISONE IMPURITY F [EP IMPURITY]
Common Name English
CORTIFEN
Brand Name English
4-PREGNEN-17.ALPHA.,21-DIOL-3,20-DIONE
Common Name English
17,21-DIHYDROXYPROGESTERONE
Common Name English
CORTEXOLONE
Common Name English
SKF-3050
Common Name English
11-DEOXYCORTISONE
Common Name English
11-DESOXY-17-HYDROXYCORTICOSTERONE [MI]
Common Name English
11-DEOXYHYDROCORTISONE
Common Name English
cortodoxone [INN]
Common Name English
SUBSTANCE S
Common Name English
SK&F-3050
Code English
NSC-18317
Code English
17.ALPHA.,21-DIHYDROXYPREGN-4-ENE-3,20-DIONE
Systematic Name English
PREGN-4-ENE-3,20-DIONE, 17,21-DIHYDROXY-
Systematic Name English
17.ALPHA.,21-DIHYDROXY-4-PREGNEN-3,20-DIONE
Systematic Name English
17.ALPHA.,21-DIHYDROXYPROGESTERONE
Common Name English
4-PREGNENE-17.ALPHA.,21-DIOL-3,20-DIONE
Common Name English
CORTODOXONE [USAN]
Common Name English
17-HYDROXY-11-DEOXYCORTICOSTERONE
Common Name English
REICHSTEIN'S SUBSTANCE S
Common Name English
.DELTA.4-PREGNENE-17.ALPHA.,21-DIOL-3,20-DIONE
Common Name English
CORTISOL, 11-DEOXY-
Common Name English
17,21-Dihydroxypregn-4-ene-3,20-dione
Systematic Name English
17.ALPHA.-HYDROXYCORTEXONE
Common Name English
11-DESOXY-17.ALPHA.-HYDROXYCORTICOSTERONE
Common Name English
Classification Tree Code System Code
LOINC 55809-8
Created by admin on Mon Mar 31 17:35:01 GMT 2025 , Edited by admin on Mon Mar 31 17:35:01 GMT 2025
LOINC 13872-7
Created by admin on Mon Mar 31 17:35:01 GMT 2025 , Edited by admin on Mon Mar 31 17:35:01 GMT 2025
CFR 21 CFR 862.1185
Created by admin on Mon Mar 31 17:35:01 GMT 2025 , Edited by admin on Mon Mar 31 17:35:01 GMT 2025
LOINC 34206-3
Created by admin on Mon Mar 31 17:35:01 GMT 2025 , Edited by admin on Mon Mar 31 17:35:01 GMT 2025
LOINC 1657-6
Created by admin on Mon Mar 31 17:35:01 GMT 2025 , Edited by admin on Mon Mar 31 17:35:01 GMT 2025
LOINC 53339-8
Created by admin on Mon Mar 31 17:35:01 GMT 2025 , Edited by admin on Mon Mar 31 17:35:01 GMT 2025
LOINC 53338-0
Created by admin on Mon Mar 31 17:35:01 GMT 2025 , Edited by admin on Mon Mar 31 17:35:01 GMT 2025
NCI_THESAURUS C521
Created by admin on Mon Mar 31 17:35:01 GMT 2025 , Edited by admin on Mon Mar 31 17:35:01 GMT 2025
LOINC 42572-8
Created by admin on Mon Mar 31 17:35:01 GMT 2025 , Edited by admin on Mon Mar 31 17:35:01 GMT 2025
LOINC 14567-2
Created by admin on Mon Mar 31 17:35:01 GMT 2025 , Edited by admin on Mon Mar 31 17:35:01 GMT 2025
LOINC 34205-5
Created by admin on Mon Mar 31 17:35:01 GMT 2025 , Edited by admin on Mon Mar 31 17:35:01 GMT 2025
LOINC 45184-9
Created by admin on Mon Mar 31 17:35:01 GMT 2025 , Edited by admin on Mon Mar 31 17:35:01 GMT 2025
LOINC 50071-0
Created by admin on Mon Mar 31 17:35:01 GMT 2025 , Edited by admin on Mon Mar 31 17:35:01 GMT 2025
LOINC 25315-3
Created by admin on Mon Mar 31 17:35:01 GMT 2025 , Edited by admin on Mon Mar 31 17:35:01 GMT 2025
LOINC 34204-8
Created by admin on Mon Mar 31 17:35:01 GMT 2025 , Edited by admin on Mon Mar 31 17:35:01 GMT 2025
Code System Code Type Description
SMS_ID
100000084270
Created by admin on Mon Mar 31 17:35:01 GMT 2025 , Edited by admin on Mon Mar 31 17:35:01 GMT 2025
PRIMARY
CAS
152-58-9
Created by admin on Mon Mar 31 17:35:01 GMT 2025 , Edited by admin on Mon Mar 31 17:35:01 GMT 2025
PRIMARY
MERCK INDEX
m4203
Created by admin on Mon Mar 31 17:35:01 GMT 2025 , Edited by admin on Mon Mar 31 17:35:01 GMT 2025
PRIMARY Merck Index
CHEBI
28324
Created by admin on Mon Mar 31 17:35:01 GMT 2025 , Edited by admin on Mon Mar 31 17:35:01 GMT 2025
PRIMARY
ECHA (EC/EINECS)
205-805-2
Created by admin on Mon Mar 31 17:35:01 GMT 2025 , Edited by admin on Mon Mar 31 17:35:01 GMT 2025
PRIMARY
PUBCHEM
440707
Created by admin on Mon Mar 31 17:35:01 GMT 2025 , Edited by admin on Mon Mar 31 17:35:01 GMT 2025
PRIMARY
FDA UNII
WDT5SLP0HQ
Created by admin on Mon Mar 31 17:35:01 GMT 2025 , Edited by admin on Mon Mar 31 17:35:01 GMT 2025
PRIMARY
EPA CompTox
DTXSID8045642
Created by admin on Mon Mar 31 17:35:01 GMT 2025 , Edited by admin on Mon Mar 31 17:35:01 GMT 2025
PRIMARY
ChEMBL
CHEMBL253144
Created by admin on Mon Mar 31 17:35:01 GMT 2025 , Edited by admin on Mon Mar 31 17:35:01 GMT 2025
PRIMARY
WIKIPEDIA
CORTODOXONE
Created by admin on Mon Mar 31 17:35:01 GMT 2025 , Edited by admin on Mon Mar 31 17:35:01 GMT 2025
PRIMARY
INN
1830
Created by admin on Mon Mar 31 17:35:01 GMT 2025 , Edited by admin on Mon Mar 31 17:35:01 GMT 2025
PRIMARY
EVMPD
SUB06810MIG
Created by admin on Mon Mar 31 17:35:01 GMT 2025 , Edited by admin on Mon Mar 31 17:35:01 GMT 2025
PRIMARY
NCI_THESAURUS
C80813
Created by admin on Mon Mar 31 17:35:01 GMT 2025 , Edited by admin on Mon Mar 31 17:35:01 GMT 2025
PRIMARY
MESH
C058175
Created by admin on Mon Mar 31 17:35:01 GMT 2025 , Edited by admin on Mon Mar 31 17:35:01 GMT 2025
PRIMARY
NSC
18317
Created by admin on Mon Mar 31 17:35:01 GMT 2025 , Edited by admin on Mon Mar 31 17:35:01 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Related Record Type Details
ACTIVE MOIETY